LN-480431
avidinorubicin , 135447-13-1
Update time: 2023-04-23
PRODUCT Properties
| Density | 1.44±0.1 g/cm3(Predicted) |
| pka | 4.37±0.17(Predicted) |
Description and Uses
Avidinorubicin is a novel anthracycline with platelet aggregation inhibitory activity.
Avidinorubicin is an antimicrobial agent found in Streptomyces avidinii, exhibiting activity against both Gram-positive and Gram-negative bacteria. Additionally, Avidinorubicin inhibits thrombin (HY-114164)-induced platelet aggregation, with an IC50 of 7.9 μM[1].